Metabolic syndrome and insulin resistance in patients with chronic hepatitis C

Terapevticheskii Arkhiv

Volumn 82, Issue 10, 2010, Pages 51-56

  Baizhanova, Zh Zh ^a   Ignatova, T M ^b   Nekrasova, T P ^a  

^a I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Antiviral therapy; Chronic hepatitis C; Fibrosis; Hepatic steatosis; Insulin resistance; Metabolic syndrome

Indexed keywords

ANTIVIRUS AGENT; LEPTIN;

ADULT; ARTICLE; BLOOD; DRUG EFFECT; FATTY LIVER; FEMALE; GENETICS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; INSULIN RESISTANCE; ISOLATION AND PURIFICATION; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROSPECTIVE STUDY; TREATMENT OUTCOME; VIROLOGY;

ADULT; ANTIVIRAL AGENTS; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INCIDENCE; INSULIN RESISTANCE; LEPTIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 78650060960     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Asselach T., Rubbia-Brandt L., Marcellin P., Negro F. Steatosis in chronic hepatitis C: why does it really matter? Gut 2006; 55: 123-130.
2. Negro F. Mechanisms and significance of liver steatosis in hepatitis C virus infection. WId J. Gastroenterol. 2006; 12: 6756-6765.
3. Rubbia-Brandt L. Quadri R. Abid K. Giostra E. Male P.-J. Mentha G. Spahr L. Zarski J.-P. Borisch B. Hadengue A. Negro F. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3 Journal of Hepatology 2000 33 1 106-115 DOI 10.1016/S0168-8278(00)80166-X 3. Rubbia-Brandt L., Quadri R., Abid K. et al. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J. Hepatol. 2000; 33: 106-115. (Pubitemid 30418941)
4. Adinolfi L. E., Gambardella M., Andreana A. et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001; 33: 1358-1364.
5. Hui J.M. Sud A. Farrell G.C. Bandara P. Byth K. Kench J.G. McCaughan G.W. George J. Insulin Resistance Is Associated with Chronic Hepatitis C and Virus Infection Fibrosis Progression Gastroenterology 2003 125 6 1695-1704 DOI 10.1053/j.gastro.2003.08.032 6. Hui J. M., Sud A., Farell G. C. et al. Insulin resistance is associated with chronic hepatitis C and fibrosis progression. Gastroenterology 2003; 125: 1695-1704. (Pubitemid 37500434)
6. Moucarl R., Asselah T., Cazals-Hatem D. et al. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCVRNA level, and liver fibrosis. Gastroenterology 2008; 134: 416-423.
7. Serfaty L., Capeau J. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data. Liver Intern. 2009; 2: 13-25.
8. Douglas M. W., George J. Molecular mechanisms of insulin resistance in chronic hepatitis C. Wld J. Gastroenterol. 2009; 15: 4356-4364.
9. Third Report of National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adult (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421.
10. Matthews D.R. Hosker J.P. Rudenski A.S. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 1985 28 7 412-419 DOI 10.1007/BF00280883 11. Matthews D. R., Hosker J. P., Rudenski A. S. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. (Pubitemid 15018832)
11. Lonardo A., Loria P., Carulli N. Dismetabolic changes associated with HCV: a distinct syndrome? Intern. Emerg. Med. 2008; 3: 99-108.
12. Pandy a P. K., Shah P., Callahan P. et al. Metabolic syndrome in veterans with chronic HCV infection correlates with NAFLD activity score. Gastroenterology 2006; 130 (Suppl. 2): Abstr. S1915.
13. Grigorescu M., Radu C., Crisan D. et al. Metabolic syndrome, insulin resistance and adiponectin level in patients with chronic hepatitis C. J. Gastrointestin. Liver Dis. 2008; 17 (2): 147-154.
14. Shaheen M., Echeverry D., Oblad M. G. et al. Hepatitis C, metabolic syndrome, and inflammatory markers: results from the Third National Health and a Nutrition Examination Survey (NHANES III). Diabet. Res. Clin. Pract. 2007; 75: 320-326.
15. Yonossi Z M., McCullough A. J. Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C vims: impact on disease progression and treatment response. Liver Int. 2009; 29: 3-12.
16. Harrison S. A. Correlation between insulin resistance and hepatitis C viral load. Hepatology 2006; 43: 1168-1169.
17. Mason A. L., Lau J. Y. N., Hoang N et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 29: 328-333.
18. Zein C. O., Levy C., Basu A. et al. Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study. Am. J. Gastroenterol. 2005; 100: 48-55.
19. Petit J.-M. Bour J.-B. Galland-Jos C. Minello A. Verges B. Guiguet M. Brun J.-M. Hillon P. Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C Journal of Hepatology 2001 35 2 279-283 DOI 10.1016/S0168-8278(01)00143-X, PII S016882780100143X 20. Petit J.-M., Bour J.-B., Galland-Jos C. et al. Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. J. Hepatol, 2001; 35: 279-283. (Pubitemid 32803485)
20. Huang J.-F., Dal C.-Y., Hwang S.-J. et al. Hepatitis C viremia increases the association with type 2 diabetes mellitus in hepatitis B and C endemic area: an epidemiological link with virological implication. Am. J. Gastroenterol. 2007; 102: 1237-1243.
21. Romero-Gomez M., Del Mar Viloria M., Andrade R. J. et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 2005; 128: 636-641.
22. Lo Iacono O., Venezia G., Petta S. et al. The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. Aliment. Pharmacol. Ther. 2007; 25: 1181-1191.
23. Myers R. P., Messous D., Poynard T., Imbert-Bismut F. Association between leptin, metabolic factors and liver histology in patients with chronic hepatitis C. Can. J. Gastroenterol. 2007; 21: 289-294.
24. Romero-Gomez M., Castellano-Meglas V. M., Grande L. et al. Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C. Am. J. Gastroenterol. 2003; 1 (8): 1135-1141.
25. Manolakopoulos S., Bethanis S., Liapi C. et al. An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study. BMC Gastroenterol. 2007; 7: 17.
26. Leandro G., Magnia A., Hui J. et al. The relationship between hepatic steatosis, inflammation and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology 2006; 130: 1636-1642.
27. Charlton M.R. Pockros P.J. Harrison S.A. Impact of obesity on treatment of chronic hepatitis C Hepatology 2006 43 6 1177-1186 DOI 10.1002/hep.21239 28. Charlton M. R., Pocros P. J., Harrison S. A. Impact of obesity on treatment of chronic hepatitis C. Hepatology 2006; 43: 1177-1186. (Pubitemid 43980094)
28. Chu C.-J., Lee S.-D., Hung T.-H. et al. Insulin resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon a2b plus ribavirin. Aliment. Pharmacol. Ther. 2008; 29: 46-54.
29. Persico M., Capasso M., Persico E. et al. Suppressor of cytokine signaling 3 (SOCS) expression and hepatitis C virus-related chronic hepatitis: insulin resistance and response to antiviral therapy. Hepatology 2007; 46: 1009-1015.